TrialThe Lancet. Oncology2025

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Silke Gillessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.